Even under close evaluation, PML remains a rare disease. But as we alter the immune system, we need to understand what unintended effects it might have.
Statistically then, the risk is approximately 1 in 1,000, which is substantially higher than in the normal population. We're also careful to say we do not know what the risk is for individuals with long-term use of the drug.
This study was designed to address a critical, immediate need for patient safety in the people who participated in clinical trials of this drug.
We concluded that at this particular time there is no evidence that there are more PML cases.
We had to assess who else might be at risk.
We have found no evidence of additional cases of PML.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.